openPR Logo
Press release

Dry Eye Disease Market Epidemiology Report 2025-2035: Drug Pipeline, Treatment, Trends, Rising Incidence & prevalence

06-12-2025 02:05 PM CET | Health & Medicine

Press release from: IMARC Group

Dry Eye Disease Market Epidemiology Report 2025-2035: Drug Pipeline, Treatment, Trends, Rising Incidence & prevalence

Dry Eye Disease Market Epidemiology Report 2025-2035: Drug Pipeline, Treatment, Trends, Rising Incidence & prevalence

The 7 major dry eye disease markets reached a value of USD 3.3 Billion in 2024. Looking forward, IMARC Group expects the 7MM to reach USD 5.4 Billion by 2035, exhibiting a growth rate (CAGR) of 4.64% during 2025-2035.

The dry eye disease market is experiencing high growth due to heightened awareness of eye health, more screen usage, and development in therapeutic approaches. A frequent disorder, and in many cases chronic, dry eye takes place when the eyes produce tears inadequately or when such tears are of inferior quality. Such dryness can cause irritation, redness, blurred vision, as well as an unceasing feeling of dryness or grittiness. Due to the contemporary lifestyle that places a greater burden on the eyes than ever, the need for good dry eye treatment is growing globally.

Request for a sample of this report: https://www.imarcgroup.com/dry-eye-disease-market/requestsample

Market Overview and Expansion

By 2025, numerous products and treatments will be available for the management of dry eye, ranging from over-the-counter drops to prescription anti-inflammatory medications, medical devices, and office procedures. Dry eye, present in all age groups, is prevalent in elderly individuals, postmenopausal women, and autoimmune disease patients. With the global population growing older, it is becoming increasingly prevalent, increasing the patient population that needs long-term management.

Another key driver is the existence of new treatment alternatives. In 2025, artificial tears are no longer the only option. More advanced prescription drugs seek to address the underlying inflammation, enhance tear production, and bring long-term relief. Stimulating devices for the tear glands or lid margin cleaning are also increasingly popular, providing non-invasive solutions to the usual treatments.

In addition, greater engagement of eye care practitioners within primary care environments is enhancing diagnosis and early treatment. Eye doctors and eye doctors are now employing sophisticated diagnostic technologies to detect dry eye disease more precisely and tailor the treatment accordingly. Such patient-focused care is enhancing effectiveness and stimulating growth in the market.

Emerging Trends and Future Outlook

One of the key trends influencing the dry eye disease market in 2025 is the expansion of personalized eye care. Products for various severity and etiology levels of dry eye are increasingly popular. On top of that, digital health technology like apps and smart devices are being utilized to track symptoms, promote medication compliance, and record environmental triggers.

The market is also witnessing growth in consumer-focused solutions. Consumers are now seeking convenience, sustained relief, and products that fit seamlessly into their lifestyle. These demands are pushing formulation, packaging, and delivery mechanisms to innovate.

Ask the Analyst for Customization and Get Full Insights with TOC: https://www.imarcgroup.com/request?type=report&id=22249&flag=E

The report also provides a detailed analysis of the current dry eye disease marketed drugs and late-stage pipeline drugs.

In-Market Drugs

Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Drug Uptake and Market Performance

Late-Stage Pipeline Drugs

Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Drug Uptake and Market Performance

Competitive Landscape:

The competitive landscape of the dry eye disease market has been studied in the report with the detailed profiles of the key players operating in the market.

Bausch + Lomb
Viatris
Alcon
HanAll BioPharma
Oculis
Stuart Therapeutics
Okyo Pharma

Countries Covered

United States
Germany
France
United Kingdom
Italy
Spain
Japan

IMARC Group Offers Other Reports:

BK Virus Infection Market https://www.openpr.com/news/4054659/bk-virus-infection-market-size-in-the-7mm-is-estimated-to-exceed

Pneumonia Market https://www.openpr.com/news/4054802/pneumonia-market-size-epidemiology-trends-treatment

Psoriasis Market https://www.openpr.com/news/4054980/psoriasis-market-size-in-the-7mm-is-estimated-to-exceed-usd-38-4

Type 2 diabetes market https://www.openpr.com/news/4055883/type-2-diabetes-market-size-epidemiology-treatment-and-top

Fabry Disease Market https://www.openpr.com/news/4055970/fabry-disease-market-size-in-the-7mm-is-estimated-to-exceed-usd

Contact US:

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145

About Us:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services.

IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dry Eye Disease Market Epidemiology Report 2025-2035: Drug Pipeline, Treatment, Trends, Rising Incidence & prevalence here

News-ID: 4064171 • Views:

More Releases from IMARC Group

Green Urea Production Cost Analysis 2025: Future Outlook and Projections
Green Urea Production Cost Analysis 2025: Future Outlook and Projections
Urea, an essential nitrogen-based compound, is widely used in fertilizers, resins, and various industrial applications. Green synthesis of urea emphasizes environmentally friendly methods, often utilizing renewable feedstocks, energy-efficient processes, and reduced carbon emissions compared to conventional production. This approach supports sustainable agriculture and minimizes ecological impact by integrating cleaner technologies. Setting up a urea production plant through green synthesis requires careful planning of feedstock sourcing, energy optimization, and advanced catalytic processes.
Ammonium Acetate Production Cost Report 2025: Project Setup, Machinery & Requirements
Ammonium Acetate Production Cost Report 2025: Project Setup, Machinery & Require …
Ammonium acetate is a white, crystalline salt formed from the neutralization of acetic acid with ammonia. It is highly soluble in water and commonly used as a buffering agent in biochemical applications, a food additive, and an intermediate in pharmaceuticals. Its versatility also extends to applications in textile dyeing, metal treatments, and as a reagent in various laboratory processes due to its stability and effectiveness in maintaining pH balance. Setting up
Carbon Steel Fastener Manufacturing Plant Setup: Costs, CapEx/OpEx and Profitability
Carbon Steel Fastener Manufacturing Plant Setup: Costs, CapEx/OpEx and Profitabi …
A carbon steel fastener is a specialized mechanical component designed to join or secure materials in construction, automotive, and industrial applications, ensuring structural integrity and reliable connection performance. These fasteners are typically high-strength, corrosion-resistant steel components that balance tensile strength with durability to support load-bearing capacity, assembly efficiency, and long-term reliability. Their quality directly influences structural safety, operational performance, and overall system effectiveness. Setting up a carbon steel fastener manufacturing plant
Sulfuric Acid Production Cost Analysis 2025: Detailed Guide on Plant Setup, CapEx/OpEx and Profitability
Sulfuric Acid Production Cost Analysis 2025: Detailed Guide on Plant Setup, CapE …
Sulfuric acid (H2SO4) is a highly corrosive, dense, and oily liquid widely recognized as one of the most important industrial chemicals. It plays a critical role in various sectors, including fertilizer manufacturing, petroleum refining, mineral processing, and chemical synthesis. Known for its strong acidic and dehydrating properties, sulfuric acid serves as a fundamental raw material in global industrial production, making it a cornerstone of modern manufacturing processes. Setting up a sulfuric

All 5 Releases


More Releases for Drug

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase